Literature DB >> 7549024

The precipitating factor in coeliac disease.

H Wieser1.   

Abstract

In recent years, remarkable progress has been made in the elucidation of cereal protein structure and its relation to coeliac toxicity. Gluten proteins of wheat can be classified according to their primary structure into high-, medium- and low-molecular-weight (HMW, MMW, LMW) groups. Each of these groups contains two or three different protein types having partly homologous, partly unique, structural elements: chi- and gamma-type HMW subunits of glutenin (HMW group), omega 5 and omega 1,2-type gliadins (MMW group) and alpha-type gliadins, gamma-type gliadins and LMW subunits of glutenin (LMW group). Numerous proteins from the same type do exist with only a few modifications of the amino-acid sequence. The structure of the HMW and LMW group proteins can be divided into three and five domains, respectively. Most typical for each type and unique for cereals are the glutamine- and proline-rich domains containing repetitive sequences (HMW group: domain B; LMW group: domain I). omega-type gliadins consist almost entirely of repetitive sequences. Rye and barley, closely related to wheat, have protein types homologous to those of wheat. Early investigations showed that wheat gluten and, in particular, the alcohol-soluble gliadin fraction contained the factor toxic for coeliac patients. Equivalent protein fractions of rye, barley and probably oats were also considered to be toxic. The effects of toxic proteins were not destroyed by digestion with pepsin, trypsin and pancreatin. In-vivo (instillation) testing established the toxicity of alpha-type gliadins, and in-vitro (organ culture) testing of gliadin peptides demonstrated that the N-terminal region (domain I) of alpha-type gliadins is involved in activating coeliac disease. The longest sequences common for toxic peptides were found to be -Pro-Ser-Gln-Gln- and -Gln-Gln-Gln-Pro-. Various in-vitro tests and two in-vivo studies on synthetic peptides support the importance of one or both of these sequences. They do not occur in non-toxic food proteins and are characterized by their ability to form a beta-turn conformation. Although these sequences are probably not sufficient for toxicity in themselves, and other amino-acid residues are additionally required, they could serve as the starting point for further investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549024     DOI: 10.1016/0950-3528(95)90027-6

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  16 in total

1.  Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.

Authors:  S M Stenman; K Lindfors; J I Venäläinen; A Hautala; P T Männistö; J A Garcia-Horsman; A Kaukovirta-Norja; S Auriola; T Mauriala; M Mäki; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2010-06-15       Impact factor: 4.330

2.  Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease?

Authors:  Na Tian; Irene Messana; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Tiziana Cabras; Alfredo D'Alessandro; Detlef Schuppan; Massimo Castagnola; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2015-04-24       Impact factor: 3.494

3.  Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

Authors:  Greetje J Tack; Jolanda M W van de Water; Maaike J Bruins; Engelina M C Kooy-Winkelaar; Jeroen van Bergen; Petra Bonnet; Anita C E Vreugdenhil; Ilma Korponay-Szabo; Luppo Edens; B Mary E von Blomberg; Marco W J Schreurs; Chris J Mulder; Frits Koning
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

4.  Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease.

Authors:  R P Anderson; D A van Heel; J A Tye-Din; D P Jewell; A V S Hill
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

5.  Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.

Authors:  Na Tian; Guoxian Wei; Detlef Schuppan; Eva J Helmerhorst
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

Review 6.  The immune recognition of gluten in coeliac disease.

Authors:  R Ciccocioppo; A Di Sabatino; G R Corazza
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

7.  Experimental Strategy to Discover Microbes with Gluten-degrading Enzyme Activities.

Authors:  Eva J Helmerhorst; Guoxian Wei
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-05-05

8.  The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.

Authors:  M Fernandez-Feo; G Wei; G Blumenkranz; F E Dewhirst; D Schuppan; F G Oppenheim; E J Helmerhorst
Journal:  Clin Microbiol Infect       Date:  2013-05-28       Impact factor: 8.067

9.  Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

Authors:  Matthew Siegel; Jiang Xia; Chaitan Khosla
Journal:  Bioorg Med Chem       Date:  2007-06-13       Impact factor: 3.641

10.  Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.

Authors:  Maram Zamakhchari; Guoxian Wei; Floyd Dewhirst; Jaeseop Lee; Detlef Schuppan; Frank G Oppenheim; Eva J Helmerhorst
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.